Latest Regulatory News

Resources & Energy Group Limited (REZ) has secured approval to expand gold vat leach production at its East Menzies Gold Project, transitioning from trial to commercial scale. The company also announced a maiden JORC 2012 Inferred Mineral Resource at Gigante Grande, underpinning future growth.

Tryptamine Therapeutics has initiated the world’s first clinical trial of its IV-infused psilocin drug, TRP-8803, targeting Binge Eating Disorder, alongside a pioneering EEG biomarker collaboration and new funding.

Challenger Gold Limited advances its Hualilan Gold Project with commissioning of the Casposo Toll Milling plant and key operational contracts, while Ecuador projects gain value following Lumina Gold’s takeover. A $30 million placement strengthens funding for upcoming milestones.

ANZ Group Holdings Limited has announced a 1.5% discount on shares acquired through its Dividend Reinvestment and Bonus Option Plans for the upcoming 2025 final dividend, signaling a subtle shift in shareholder incentives.

BDO South Africa has completed its review of Renergen Limited’s interim financial statements, confirming compliance but highlighting significant uncertainties over the company’s future viability.

Locate Technologies has dispatched its Scheme Booklet to shareholders, outlining the proposed acquisition by Locate NZ and urging a vote in favour at the upcoming virtual meeting.

Kore Potash has made significant strides in financing and early development activities for its Kola Potash Project, while updating environmental assessments to reflect design changes. The company holds a cash balance of US$2.13 million as it prepares for construction.

NuEnergy Gas Limited reported a cash outflow for the September quarter, continuing its exploration spend while progressing an early gas sales initiative and preparing for further capital raising.

NuEnergy Gas Limited has completed drilling three wells and commenced initial gas sales at its Tanjung Enim PSC in Indonesia, marking a key step toward full-scale production. Regulatory approvals and commercial agreements are advancing, positioning the company for growth in the unconventional gas sector.

Betashares Capital Ltd has announced the final distribution amounts for October 2025 across multiple ETFs listed on the ASX AQUA market, alongside details on the Distribution Reinvestment Plan (DRP) and key dates for investors.

Kinetiko Energy has reported record gas flow rates from its Brakfontein test wells, renewed critical exploration rights, and signed a joint venture to develop a pilot LNG plant, marking a significant step towards commercial gas production in South Africa.

InhaleRx has secured FDA alignment and ethics approvals to progress clinical trials for its inhaled therapies targeting breakthrough cancer pain and panic disorder, with patient dosing set to begin soon.